Recognition of prostate-specific antigenic peptide determinants by human CD4 and CD8 T cells

Clinical and Experimental Immunology

Volumn 114, Issue 2, 1998, Pages 166-172

  Corman, J M ^a   Sercarz, E E ^a,b   Nanda, N K ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Antigenic; CD4 T cell; CD8 T cell; Determinant; Human prostate cancer; PSA; PSM; T cell repertoire

Indexed keywords

EPITOPE; HLA A1 ANTIGEN; HLA DR4 ANTIGEN; MEMBRANE ANTIGEN; PROSTATE SPECIFIC ANTIGEN; SYNTHETIC PEPTIDE;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HLA TYPING; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; T LYMPHOCYTE SUBPOPULATION;

ADULT; AMINO ACID SEQUENCE; ANTIGENS, SURFACE; CARBOXYPEPTIDASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; GLUTAMATE CARBOXYPEPTIDASE II; HLA-DR4 ANTIGEN; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PROSTATE-SPECIFIC ANTIGEN;

EID: 0031789485     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00678.x     Document Type: Article

References (22)

1. Houghton AN. Cancer antigens: immune recognition of self and altered self. J Exp Med 1994; 180:1-4.
2. Coulie PG, Brichard V, Van Pel A et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994; 180:35-42.
3. Nanda NK, Sercarz EE. Induction of anti-self immunity to cure cancer. Cell 1995; 82:13-17.
4. Watt KWK, Lee PM, Timkulu T et al. Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc Natl Acad Sci USA 1986; 83:3166-70.
5. Israeli RS, Powell CT, Fair WR et al. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 1993; 53:227-30.
6. Sercarz EE, Lehmann PV, Ametani A et al. Dominance and crypticity of T cell antigenic determinants. Ann Rev Immunol 1993; 11:729-66.
7. Ostrand-Rosenberg S. Tumor immunotherapy: the tumor cell as an antigen-presenting cell. Curr Opin Immunol 1994; 6:722-7.
8. Terasaki PI, Bernoco D, Park MS et al. Microdroplet testing for HLA-A, -B, -C and -D antigens. Am J Clin Pathol 1978; 69:103-18.
9. Rammensee HG, Friede T, Stevanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995; 41:178-228.
10. Sullivan DO, Arrhenius TS, del Guercio MF et al. On the interaction of promiscuous antigenic peptides with different DR alleles. J Immunol 1991; 147:2663-9.
11. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; (Suppl. 97) (paper IV):229-35.
12. + T-cell lines specific for HIV gp120. J Acq Immunol Def Syndr 1994; 7:15-23.
13. Ota K, Matsui M, Millford EL et al. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990; 346:183-7.
14. Piebanski M, Allsopp CEM, Aidoo M et al. Induction of peptide specific primary cytotoxic T lymphocyte responses from human peripheral blood. Eur J Immunol 1994; 25:1783-7.
15. Nanda NK, Nath I. Characteristics of histamine receptors present on suppressor T cell in 'healthy individuals'. Int J Immunopharmacol 1985; 7:587-95.
16. Ostergaard HL, Clark WR. Evidence for multiple lytic pathways used by cytotoxic T lymphocytes. J Immunol 1989; 143:2120-6.
17. Pullen AM, Kappler JW, Marrack P. Tolerance to self-antigen shapes T cell repertoire. Immunologic Rev 1989; 107:125-39.
18. McCormack JE, Callahan JE, Kappler J et al. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol 1993; 150:3785-92.
19. Lanzavecchia A. How can cryptic epitopes trigger autoimmunity? J Exp Med 1995; 181:1945-8.
20. Cibotti R, Kanellopoulos JM, Cabaniols JP et al. Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants. Proc Natl Acad Sci USA 1992; 89:416-20.
21. Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996; 271:1723-6.
22. Hahne M, Rimoldi D, Schroter M et al. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 1996; 274:1363-6.